Searched for
GOLDMAN SACHS REPORT INDIA
Buy, Sell or Hold? Goldman Sachs maintains a buy on Eternal; Citi recommends sell rating on Dr Reddy’s Laboratories post Q1 resultsGoldman Sachs and Citi have issued fresh post-Q1 calls on three stocks. Goldman stays bullish on Eternal (Buy, target Rs 345, 21% upside) d...
Oil at $90-100 will impact macros and the market: Sunil Koul, Goldman SachsGlobal investors show increased interest in India's equity markets recently. Corporate earnings and economic performance have remained quit...
India's auto parts industry to clock 10% annual growth on semiconductor, defence, EV push: Goldman SachsIndia's auto parts sector will grow ten percent annually through fiscal year thirty. Diversification into semiconductors and defence will f...
US Stock Market: Goldman Sachs launches new private markets platform to expand offerings for wealthy clientsGoldman Sachs has launched a new platform to expand private market offerings. Investor demand for access to privately held companies contin...
$120 crude oil scare is back & India has plenty at stakeGoldman Sachs has warned Brent crude could rise above $120 a barrel if disruptions in the Strait of Hormuz persist. For India, which import...
Goldman raises Dutch TTF gas price view on slow Hormuz export recoveryGoldman Sachs raised its Dutch TTF gas price forecasts for the final two quarters of 2025, citing expectations of further delays in the nor...
Oil prices to hit $120 soon? Goldman Sachs makes big prediction as Hormuz concerns loomGoldman Sachs has warned Brent crude could spike to $120 per barrel if disruptions through the Strait of Hormuz persist, though its base ca...
Goldman Sachs initiates coverage on Sansera Engineering, 3 other auto ancillary stocks with upside of up to 28%. Here’s whyGoldman Sachs has initiated coverage on four Indian auto ancillary companies, turning bullish on Sansera Engineering and Craftsman Automati...
Wall Street banks are having their best trading year since 2009. Does that mean a crash is coming?Wall Street banks are on track for record trading revenue, driven by AI investing, dealmaking and active markets rather than crisis conditi...
LetterOne taps Rahul Mukim to spearhead $2 billion India pushLuxembourg-based LetterOne appointed Rahul Mukim to lead its India investments. The firm plans a significant $2 billion investment program ...
Q1 results today: Jio Financial, Wipro, Polycab India, BHEL among 41 companies to report earningsThe June quarter earnings season gathers pace on July 16, with 41 companies, including Jio Financial Services, Wipro, Tech Mahindra, BHEL, ...
Morgan Stanley beats profit estimates on dealmaking boost, strong tradingMorgan Stanley has showcased an impressive performance for the second quarter, surpassing Wall Street's earnings expectations. The surge in...
Earnings Boost: Why Goldman Sachs shares jumped to record highsGoldman Sachs shares climbed to a record high after the investment bank posted stronger-than-expected second-quarter earnings, driven by re...
Goldman Sachs profit tops estimates on trading boom, corporate deal spreeGoldman Sachs has reported robust profits for the second quarter, surpassing analysts' predictions. The firm's equities revenue soared to u...
Data center firm Switch taps banks for IPO that could value it up to $80 billionData center operator Switch is preparing for a significant initial public offering. This offering could potentially raise up to ten billion...
Goldman Sachs sees Nifty rallying to 26,500, signals nearly 9.5% upsideGoldman Sachs anticipates Nifty's recovery to 26500, indicating a significant upside potential. This outlook stems from lower commodity pri...
FIIs pour over $1 billion into Indian stocks, biggest weekly buying since June 2025Foreign investors bought over $1 billion worth of Indian equities last week, marking their biggest weekly purchase since June 2025. Goldman...
Goldman Sachs pegs Nifty target at 26,500 by June 2027; lists 15 stocks from key themesGoldman Sachs has turned more constructive on Indian equities, forecasting the Nifty 50 to rebound to 26,500 by June 2027. The brokerage ci...
Pharma companies' Q1 margins likely to decline despite revenue growth: Goldman SachsIndian pharmaceutical firms anticipate revenue increases in the first quarter of fiscal year twenty twenty six twenty seven. Profitability ...
Global Markets: Goldman Sachs tightens grip on EMEA M&A advisory as dealmaking hits 19-year highGoldman Sachs has significantly boosted its M&A advisory dominance in EMEA, capturing its largest market share in nearly a decade. This sur...